MLH1 and ovarian neoplasm: We and others (Brown et al, 1997; Fink et al, 1998a; Samimi et al, 2000) have shown that there is an increase in the number of ovarian tumour cells that score negative for MLH1 expression following platinum-based chemotherapy when compared with untreated tumours.